Hemophilia
Our international hemophilia courses/workshops
International course in hemophilia - from basic to advanced
Date: 8-10 October, 2024
Location: High Court, Malmö, Sweden
This is an international, case-oriented course for physicians in need of further training in hemophilia.
The aim of this course is to summarize and highlight the current state-of-the-art management of patients with a focus on personalized care and provide both basic and frontline knowledge in diagnostics, immunology and clinical management in an interactive way.
Target group: Physicians treating hemophilia from all over the world. Participants should be affiliated to a hemophilia centre and have a proven future commitment to this field. Good English-speaking skills are required.
Registration (deadline 31 August, 2024)
Advanced international hemophilia course
Date: TBD
Location: TBD
The objectives of the "advanced international course in hemophilia - from basic to advanced" is to highlight actual problems within hemophilia care and to engage the participants to clinical review of new medical evidence for treatment and follow-up. The participants should be able to use the new knowledge within this complex area in a manner that is optimum for the patient.
Target group: Physicians treating hemophilia from all over the world. Participants should be affiliated to a hemophilia centre and have a proven future commitment to this field. Good English-speaking skills are required.
ITI School in Hemophilia
Date: TBD
An international course for physicians in need of further training in ITI (immune tolerance induction) therapy.
Target group: physicians treating hemophilia. Participants should have previous ITI experience. Good English skills are required.
The aim of the course is to highlight latest knowledge, current challenges of ITI treatment and different therapeutic options - in an era of new potential approaches to assure the best care of patients who have developed inhibitors.
Nordic Hemophilia Multidisciplinary Workshop
Date: TBD
Location: TBD
Target group: Physicians, nurses and physiotherapists treating hemophilia in the Nordic area.